CEPEN - CENTRO DE PESQUISA E ENSINO DE SANTA CATARINA
CEPEN - CENTRO DE PESQUISA E ENSINO DE SANTA CATARINA
R. Menino Deus, 63 - Bloco A - 3º andar - Sala 306 | 4º andar - Sala 410 - Centro, Florianópolis - SC, 88020-210
Select an option
I am a doctor
I am a sponsor
Open studies
Prostate cancer
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) - KLK2-comPAS - Janssen Research & Development, LLCSee more
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) - KLK2-comPAS - Janssen Research & Development, LLCSee more
Colorectal cancer
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) - MK-1084-012/KANDLELIT-012 - Merck Sharp & Dohme LLCSee more
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) - MK-1084-012/KANDLELIT-012 - Merck Sharp & Dohme LLCSee more
Lung cancer
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007) - KANDLELIT-007 - Merck Sharp & Dohme LLCSee more
Myeloproliferative syndromes
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis - PACIFICA - Swedish Orphan BiovitrumSee more
Non-Hodgkin Lymphoma
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) - waveLINE-010 - Merck Sharp & Dohme LLCSee more
